Literature DB >> 25879281

The NLRP1 inflammasomes.

Joseph Chavarría-Smith1, Russell E Vance.   

Abstract

Inflammasomes are cytosolic protein complexes that serve as platforms for the recruitment and activation of the pro-inflammatory CASPASE-1 protease. CASPASE-1 activation leads to processing and maturation of the cytokines interleukin-1β and interleukin-18 and a lytic form of cell death termed pyroptosis. Inflammasome assembly is initiated by cytosolic sensors in response to microbial infections. Many of these sensors, including NLRP1 (NLR family, pyrin domain containing 1), are described to form an inflammasome, but until recently, the mechanism of inflammasome activation and its physiological functions in host defense have remained unclear. In the last few years, important advances in our understanding of NLRP1 biology have been achieved. In this review, we discuss the activation of NLRP1 by various stimuli, including Bacillus anthracis lethal toxin, Toxoplasma gondii, muramyl dipeptide, and host intracellular ATP depletion. The role NLRP1 plays in pathogen recognition and resistance during infection is also discussed, as is the regulation of NLRP1 by host and viral proteins. We conclude by discussing the unexpected differences in the mechanism of NLRP1 inflammasome activation, as compared to the activation of other inflammasomes, such as the NAIP (NLR family, apoptosis inhibitory protein)/NLRC4 inflammasomes.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NLRP1; caspase-1; inflammasome; innate immunity; lethal toxin

Mesh:

Substances:

Year:  2015        PMID: 25879281     DOI: 10.1111/imr.12283

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  77 in total

1.  The inflammasome: firing up innate immunity.

Authors:  Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

2.  Listeria monocytogenes and Shigella flexneri Activate the NLRP1B Inflammasome.

Authors:  Jana Neiman-Zenevich; Sarah Stuart; Mena Abdel-Nour; Stephen E Girardin; Jeremy Mogridge
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 3.  Inflammasomes, the eye and anti-inflammasome therapy.

Authors:  P Yerramothu; A K Vijay; M D P Willcox
Journal:  Eye (Lond)       Date:  2017-11-24       Impact factor: 3.775

Review 4.  The Role of Neuronal NLRP1 Inflammasome in Alzheimer's Disease: Bringing Neurons into the Neuroinflammation Game.

Authors:  Jeremy Kean Yi Yap; Benjamin Simon Pickard; Elaine Wan Ling Chan; Sook Yee Gan
Journal:  Mol Neurobiol       Date:  2019-05-20       Impact factor: 5.590

Review 5.  [Inflammasome and gout].

Authors:  M Aringer; C Hedrich; A-K Tausche
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

Review 6.  The NLRP1 inflammasome: new mechanistic insights and unresolved mysteries.

Authors:  Patrick S Mitchell; Andrew Sandstrom; Russell E Vance
Journal:  Curr Opin Immunol       Date:  2019-05-20       Impact factor: 7.486

7.  NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.

Authors:  Jesus A Segovia; Te-Hung Chang; Vicki T Winter; Jacqueline J Coalson; Marianna P Cagle; Lavanya Pandranki; Santanu Bose; Joel B Baseman; Thirumalai R Kannan
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

8.  Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis.

Authors:  Scott B Drutman; Filomeen Haerynck; Franklin L Zhong; David Hum; Nicholas J Hernandez; Serkan Belkaya; Franck Rapaport; Sarah Jill de Jong; David Creytens; Simon J Tavernier; Katrien Bonte; Sofie De Schepper; Jutte van der Werff Ten Bosch; Lazaro Lorenzo-Diaz; Andy Wullaert; Xavier Bossuyt; Gérard Orth; Vincent R Bonagura; Vivien Béziat; Laurent Abel; Emmanuelle Jouanguy; Bruno Reversade; Jean-Laurent Casanova
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-04       Impact factor: 11.205

9.  SLC46 Family Transporters Facilitate Cytosolic Innate Immune Recognition of Monomeric Peptidoglycans.

Authors:  Donggi Paik; Amanda Monahan; Daniel R Caffrey; Roland Elling; William E Goldman; Neal Silverman
Journal:  J Immunol       Date:  2017-05-24       Impact factor: 5.422

10.  The MC4 receptor agonist RO27-3225 inhibits NLRP1-dependent neuronal pyroptosis via the ASK1/JNK/p38 MAPK pathway in a mouse model of intracerebral haemorrhage.

Authors:  Shengpan Chen; Yuchun Zuo; Lei Huang; Prativa Sherchan; Jian Zhang; Zhengtao Yu; Jianhua Peng; Junyi Zhang; Lianhua Zhao; Desislava Doycheva; Fei Liu; John H Zhang; Ying Xia; Jiping Tang
Journal:  Br J Pharmacol       Date:  2019-04-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.